Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000009.xml
Am J Perinatol 2003; 20(8): 415-424
DOI: 10.1055/s-2003-45385
DOI: 10.1055/s-2003-45385
REVIEW ARTICLE
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662
Hyperbilirubinemia in the 2000s: What Should We Do Next?
Gail Ross- Department of Pediatrics, Weill Medical College of Cornell University, New York, New York
Further Information
Publication History
Publication Date:
02 January 2004 (online)
ABSTRACT
Changes in healthcare policy mandating early discharge of healthy, full-term infants and the higher prevalence of breast-feeding of newborns have contributed to an increased number of term infants being readmitted to the hospital for hyperbilirubinemia. At high levels, total serum bilirubin causes kernicterus, which is associated with severe neurological sequelae. This article provides a review of prior studies that have examined whether and at what levels total serum bilirubin affects neurodevelopmental outcome in term infants. In addition, the article reviews some approaches in the literature that suggest means of preventing high levels of hyperbilirubinemia in term infants.
KEYWORDS
Hyperbilirubinemia - kernicterus - total serum bilirubin - neurodevelopmental outcome
REFERENCES
- 1 Davidson L T, Merritt K K, Weech A A. Hyperbilirubinemia in the newborn. Am J Dis Child . 1941; 61 958-980
- 2 Maisels M J, Gifford K, Antle C E. et al . Normal serum bilirubin levels in the newborn and the effect of breast feeding. Pediatrics . 1986; 78 837-843
- 3 Palmer C, Mujsce D J. Common neonatal illnesses. In: Hoekelman RA, ed. Primary Pediatric Care St. Louis: Mosby; 2001: 587-599
- 4 Harris M C, Bernbaum J C, Polin J R. et al . Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics . 2001; 107 1075-1080
- 5 Newman T B, Escobar G J, Gonzales V. et al . Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics . 1999; 104 1198-1203
- 6 Bhutani V K, Johnson L H, Sivieri E M. Risk assessment of hyperbilirubinemia in near-term newborns. Pediatrics . 1999; 104 (suppl 3) 741
- 7 Volpe J J. Bilirubin and brain injury. Neurology and the Newborn. 4th ed. Philadelphia: WB Saunders; 2001: 521-546
- 8 Bratlid D, Cashore W J, Oh W. Effect of serum hyperosmalality on opening of blood-brain barrier for bilirubin in rat brain. Pediatrics . 1983; 71 909-912
- 9 Ives N K, Cox D WG, Gardiner R M. et al . The effects of bilirubin on brain energy metabolism during normoxia and hypoxia: an in vitro study using nuclear magnetic resonance spectroscopy. Pediatr Res . 1988; 23 569-573
- 10 Dennery P A, Seidman D S, Stevenson D K. Neonatal hyperbilirubinemia. N Engl J Med . 2001; 344 581-590
- 11 Wennberg R P. Brilirubin recommendations present problems: new guidelines simplistic and untested. Pediatrics . 1992; 89 821-822
- 12 Killander A, Michaelsson M, Muller-Eberhand U. et al . Hyperbilirubinemia in full-term newborn infants: a follow-up study. Acta Paediatr Scand . 1963; 52 481-484
- 13 Johnson L, Brown A K. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics . 1999; 104 (suppl 3) 736
- 14 Gartner L M, Snyder R N, Chabon R S. et al . Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics . 1970; 45 906-917
- 15 Lee K-S, Gartner L M, Eidelman A I, Ezhuthachan S. Unconjugated hyperbilirubinemia in very low birth weight infants. Clin Perinatol . 1977; 4 305-320
- 16 Lucey J F. The unsolved problem of kernicterus in the susceptible low birth weight infant. Pediatrics . 1972; 49 646-651
- 17 Osborn L M, Lenarsky C, Oakes R C. et al . Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics . 1984; 74 371-374
- 18 Newman T B, Maisels M J. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics . 1992; 89 809-818
- 19 Watchko J F, Oski F A. Bilirubin 20 mg/dL: vingintiphobia. Pediatrics . 1983; 71 660-663
- 20 Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. American Academy of Pediatrics. Practice Parameter: management of hyperbilirubinemia in the healthy term infant. Pediatrics . 1994; 94 558-561
- 21 Valaes T. Bilirubin toxicity: the problem was solved a generation ago. Pediatrics . 1992; 89 819-821
- 22 Maisels M J, Newman T B. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics . 1995; 96 730-733
- 23 Liu L L, Clemens C J, Shay D K. et al . The safety of newborn early discharge: the Washington State experience. JAMA . 1997; 278 293-298
- 24 Johnson L, Bhutani V K. Guidelines for management of the jaundiced term and near-term infant. Current Controversies in Perinatal Care III. Clin Perinatol . 1998; 25 555-573
- 25 Bhutani V K, Johnson L, Sivieri E M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics . 1999; 103 6-14
- 26 American Academy of Pediatrics Subcommittee on Neonatal Hyperbilirubinemia. Jaundice and kernicterus. Pediatrics . 2001; 108 763-765
- 27 Johnson L, Bhutani V K. Reply to the Editor. J Pediatr . 2003; 142 214-215
- 28 Braveman P, Egerter S, Pearl M, Marchi K, Miller C. Early discharge of newborns and mothers: a critical review of the literature. Pediatrics . 1995; 96 716-726
- 29 Braveman P, Kessel W, Egerter S, Richmond J. Early discharge and evidence-based practice: good science and good judgement. JAMA . 1997; 278 334-336
- 30 Britton J R, Britton H L, Beebe S A. Early discharge of the term newborn: a continued dilemma. Pediatrics . 1994; 94 291-295
- 31 Poland R L. Preventing kernicterus: almost there. J Pediatr . 2002; 140 385-386
- 32 Hsia D Y, Allen Jr H F, Gellis S S, Diamond L K. Erytheroblastosis fetalis VII: studies of serum bilirubin in relation to kernicterus. N Engl J Med . 1952; 247 668-671
- 33 Temple C. Developmental Cognitive Neuropsychology. East Sussex, UK: Psychology Press; 1997
- 34 Kolb B, Whishaw I Q. Fundamentals of Human Neuropsychology 4th ed. New York: WH Freeman; 1998
- 35 Newman T B, Maisels M J. Does hyperbilirubinemia damage the brain of full-term infants?. Clin Perinatol . 1990; 17 331-338
- 36 Niswander K, Gordon M. The Women and Their Pregnancies. Philadelphia: WB Saunders; 1972
- 37 Boggs T, Hardy J, Frazier T. Correlation of neonatal serum total bilirubin concentration and developmental status at age eight months: preliminary report from the collaborative project. J Pediatr . 1967; 71 553-560
- 38 Scheidt P C, Mellits E D, Hardy J B. et al . Toxicity to bilirubin in neonates: infant development during the first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr . 1977; 91 292-297
- 39 Hardy J B, Peeples M O. Serum bilirubin levels in newborn infants: distributions and associations with neurological abnormalities during the first year of life. Johns Hopkins Med J . 1971; 128 265-272
- 40 Naeye R L. Amniotic fluid infections, neonatal hyperbilirubinemia, and psychomotor impairment. Pediatrics . 1978; 62 497-503
- 41 Rubin R A, Balow B, Fisch R O. Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. J Pediatr . 1979; 94 601-604
- 42 Nelson K B, Ellenberg J H. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med . 1986; 315 81-86
- 43 Bjure J, Liden G, Reinand F, Vestby A. A follow-up study of hyperbilirubinaemia in full-term infants without iso-immunization. Acta Paediatr Scand . 1961; 50 437-443
- 44 Culley P, Powell J, Waterhouse J. et al . Sequelae of neonatal jaundice. BMJ . 1970; 3 383-386
- 45 Rosta Z M, Bekefi D, Popper P. et al . Neonatal pathological jaundice: seven to nine years follow up. Acta Paediatr Acad Sci Hung . 1971; 12 317-321
- 46 Seidman D S, Paz I, Stevenson D K. et al . Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics . 1991; 88 828-833
- 47 Fohl E, Lombos O. The prognosis of neonatal hemolysis due to A-B-O imcompatibility, without exchange transfusion. Ann Paediatr . 1964; 203 279-287
- 48 Holmes G E, Miller J B, Smith E E. Neonatal bilirubinemia in production of long-term neurological deficits. Am J Dis Child . 1969; 117 395-405
- 49 Bengtsson B, Verneholt J. A follow-up study of hyperbilirubinemia in healthy full-term infants without isoimmunization. Acta Paediatr Scand . 1961; 50 437-443
- 50 Newman T N, Klebanoff M A. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics . 1993; 92 651-657
- 51 Vohr R B, Kapr D, O'Dea C. et al . Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinemia. J Pediatr . 1990; 117 288-291
- 52 Gurses D, Kilic I, Sahiner T. Effects of hyperbilirubinemia on cerebrocortical electrical activity in newborns. Pediatr Res . 2002; 52 125-130
- 53 Paludetto R, Mansi G, Raidmondi F. et al . Moderate hyperbilirubinemia induces a transient alteration of neonatal behavior. Pediatrics . 2002; 110 E50
- 54 Gupta A K, Mann S B. Is auditory brainstem response a bilirubin toxicity marker?. Am J Otolaryngol . 1998; 19 232-236
- 55 Agarwal R, Kaushal M, Agarwal R, Paul V K, Deorari A K. Early neonatal hyperbilirubinemia using first-day serum bilirubin level. Indian Pediatr . 2002; 39 724-730
- 56 Grimmer I, Berger-Jones K, Buhrer C. et al . Later neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr . 1999; 88 661-663
- 57 Soorani-Lunsing I, Woltil H A, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?. Pediatr Res . 2001; 50 701-705
- 58 Hadders-Algra M, Huisjes H J, Touwen B CL. Perinatal risk factors and minor neurological dysfunction: significance for behaviour and school achievement at nine years. Dev Med Child Neurol . 1988; 30 482-491
- 59 Gillberg I C, Gillberg C. Children with preschool minor neurodevelopmental disorders. IV: behavior and school achievement at age 13. Dev Med Child Neurol . 1989; 31 3-13
- 60 Hadders-Algra M, Groothius A MC. Quality of general movements in infancy is related to neurological dysfunction, ADHD, and aggressive behaviour. Dev Med Child Neurol . 1999; 41 381-391
- 61 Alpay F, Sarici S U, Tosuncuk H D, Serdar M A, Inanc N, Gokcay E. The value of first-day billirubin measurement in predicting the development of significant hyperbilirubinemia. Pediatrics . 2000; 106 E16
- 62 Tayaba R, Gribetz D, Gribetz I, Holzman I R. Noninvasive estimation of serum bilirubin. Pediatrics . 1998; 102 E28
- 63 Moyer V A, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med . 2000; 154 391-394
- 64 Bhutani V K, Gourley G R, Adler S, Kreamer B L, Dalin C, Johnson L H. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics . 2000; 106 E17
- 65 Vreman H J, Verter J, Oh W. et al . Interlaboratory variability of bilirubin measurements. Clin Chem . 1996; 42 869-873
- 66 Odell G B, Storey G NB, Rosenberg L A. Studies in kernicterus, III: the saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr . 1970; 76 12-2
- 67 Johnson L, Boggs R R. Bilirubin-dependent brain damage: incidence and indications for treatment. In: Odell GB, Schaffer R, Simopoulos AP, eds. Phototherapy in the Newborn: An Overview Washington DC: National Academy of Sciences 1974: 122-149
- 68 Dai J, Parry D M, Krahn J. Transcutaneous bilirubinometry: its role in the assessment of neonatal jaundice. Clin Biochem . 1997; 30 1-9
- 69 Hansen T W. Kernicterus: an international perspective. Semin Neonatol . 2002; 7 103-109
- 70 Maisels M J, Kring E. Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics . 1997; 99 599-601
- 71 Dennery P A, Rhine W D, Stevenson D K. Neonatal jaundice: what now?. Clin Pediatr (Phila) . 1995; 34 103-107
- 72 Stevenson D K, Vreman H J, Oh W. et al . Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem . 1994; 40 1934-1939
- 73 Stevenson D K, Fanaroff A A, Maisels M J. et al . Prediction of hyperbilirubinemia in near-term and term infants. J Perinatol . 2001; 21 (suppl 1) S63-S72
- 74 Newman T B, Xiong B, Gonzales V M. et al . Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med . 2000; 154 1140-1147
- 75 Seidman D S, Stevenson D K, Ergaz A. et al . Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics . 1995; 96 727-729
- 76 Brown A K, Damus K, Kim M H. et al . Factors relating to readmission of term and near-term neonates in the first two weeks of life. J Perinat Med . 1999; 27 263-275
- 77 Gartner L. Management of jaundice in the well baby. Pediatrics . 1992; 89 826-827
- 78 Gourley G R. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol . 2002; 7 135-141
- 79 Madlon-Kay D J. Maternal assessment of neonatal jaundice after hospital discharge. J Fam Pract . 2002; 51 445-448
- 80 Conrad P D, Wilkering R B, Rosenberg A A. Safety of newborn discharge in less than 36 hours in an indigent population. Am J Dis Child . 1989; 143 98-101
- 81 Johnson L, Bhutani V K. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr . 2002; 140 396-403